Form 4: Elevance Health EVP & CFO Mark Kaye Acquires Shares and Stock Options

Elevance Health's EVP & CFO, Mark Kaye, reports acquisition of common stock and employee stock options on March 1, 2024.

Summary

• Mark Kaye, EVP & CFO of Elevance Health, reported changes in beneficial ownership on March 1, 2024.
• Kaye acquired 2,755 shares of common stock at $0, increasing his direct holdings to 23,031 shares.
• He also acquired options to purchase 10,633 shares of common stock at an exercise price of $499.11, exercisable in installments starting March 1, 2025.
• The reported transactions include restricted share units that will vest in installments on March 1, 2025, March 1, 2026, and March 1, 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by the CFO suggests confidence, but it's a routine filing.

Positives

• The acquisition of shares and stock options by a high-ranking executive could be interpreted as a positive signal about the executive's confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the restricted share units and the exercisability of the stock options suggest a multi-year horizon for executive compensation.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units.
• The vesting schedules and exercise prices are generally designed to align executive interests with long-term shareholder value.
• Comparing the size and structure of Mark Kaye's equity awards to those of CFOs at peer companies like UnitedHealth Group (UNH) or CVS Health (CVS) would provide a better understanding of whether the compensation is in line with industry standards.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence from the CFO.
• The vesting and exercisability of the equity awards incentivize the CFO to focus on long-term value creation for shareholders.

Key Dates